Stanford Advisors


All Publications


  • Peptide-to-macrocyclic: structure-activity relationships studies of P110, excessive mitochondrial fission inhibitor to target cardiovascular disease Workeneh, M., Ben-Uliel, S., Zilinski, S., Davis, L., Dey, S., Shalev, D. E., Ertracht, O., Haileselassie, B., De Zotti, M., Qvit, N. WILEY. 2024